Total Payments
$2,973
2024 Payments
$123.90
Companies
35
Transactions
182
Medicare Patients
1,144
Medicare Billing
$223,473
Payment Breakdown by Category
Food & Beverage$2,814 (94.7%)
Consulting$150.00 (5.0%)
Education$8.43 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,814 | 178 | 94.7% |
| Consulting Fee | $150.00 | 1 | 5.0% |
| Education | $8.43 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $912.31 | 69 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $329.22 | 24 | $0 (2024) |
| UCB, Inc. | $161.50 | 9 | $0 (2024) |
| Alkermes, Inc. | $150.00 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $103.93 | 7 | $0 (2021) |
| Biogen, Inc. | $99.28 | 7 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $89.85 | 5 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $88.24 | 6 | $0 (2018) |
| Endogastric Solutions, Inc | $85.67 | 1 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $82.63 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.90 | 7 | Teva Pharmaceuticals USA, Inc. ($49.66) |
| 2023 | $198.60 | 13 | Teva Pharmaceuticals USA, Inc. ($86.40) |
| 2022 | $347.84 | 20 | Teva Pharmaceuticals USA, Inc. ($224.23) |
| 2021 | $301.96 | 21 | Teva Pharmaceuticals USA, Inc. ($132.36) |
| 2020 | $258.06 | 19 | Teva Pharmaceuticals USA, Inc. ($137.31) |
| 2019 | $666.14 | 41 | Alexion Pharmaceuticals, Inc. ($129.50) |
| 2018 | $465.00 | 26 | ADAPT PHARMA INC. ($50.73) |
| 2017 | $611.40 | 35 | Alkermes, Inc. ($150.00) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Central Nervous System | ||||||
| 07/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Rare Disease | ||||||
| 05/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Central Nervous System | ||||||
| 04/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Rare Disease | ||||||
| 03/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Central Nervous System | ||||||
| 02/15/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Neurology | ||||||
| 01/08/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Central Nervous System | ||||||
| 09/26/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Central Nervous System | ||||||
| 08/15/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Central Nervous System | ||||||
| 07/18/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Central Nervous System | ||||||
| 05/10/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Central Nervous System | ||||||
| 04/26/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Rare Disease | ||||||
| 01/18/2023 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Neuroscience | ||||||
| 01/11/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Rare Disease | ||||||
| 01/05/2023 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 12/13/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Central Nervous System | ||||||
| 12/13/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: Central Nervous System | ||||||
| 11/09/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Rare Disease | ||||||
| 10/18/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Central Nervous System | ||||||
| 08/31/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 290 | 477 | $122,730 | $59,852 |
| 2022 | 7 | 327 | 515 | $137,435 | $73,718 |
| 2021 | 4 | 248 | 396 | $98,170 | $48,990 |
| 2020 | 5 | 279 | 444 | $92,820 | $40,913 |
Total Patients
1,144
Total Services
1,832
Medicare Billing
$223,473
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 142 | 307 | $76,900 | $38,706 | 50.3% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 61 | 80 | $19,200 | $7,626 | 39.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 50 | 50 | $16,250 | $6,965 | 42.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 13 | 13 | $6,825 | $4,319 | 63.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $2,925 | $2,100 | 71.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 14 | $630.00 | $136.68 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 140 | 325 | $81,475 | $42,561 | 52.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 76 | 76 | $24,700 | $12,426 | 50.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 47 | 47 | $10,575 | $7,869 | 74.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 15 | 15 | $7,875 | $5,387 | 68.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $4,800 | $2,097 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 21 | $4,410 | $1,815 | 41.2% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 15 | 15 | $3,600 | $1,563 | 43.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 103 | 200 | $50,000 | $26,948 | 53.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 74 | 74 | $24,050 | $12,266 | 51.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 97 | $20,370 | $8,440 | 41.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 25 | $3,750 | $1,335 | 35.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 116 | 221 | $48,045 | $21,594 | 44.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 59 | 59 | $17,675 | $8,714 | 49.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 61 | 110 | $21,300 | $8,713 | 40.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 35 | $4,850 | $1,684 | 34.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 18 | 19 | $950.00 | $208.82 | 22.0% |
About Dr. A Jaffer, MD
Dr. A Jaffer, MD is a Neurology healthcare provider based in Hemet, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225025422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. A Jaffer, MD has received a total of $2,973 in payments from pharmaceutical and medical device companies, with $123.90 received in 2024. These payments were reported across 182 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,814).
As a Medicare-enrolled provider, Jaffer has provided services to 1,144 Medicare beneficiaries, totaling 1,832 services with total Medicare billing of $223,473. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Hemet, CA
- Active Since 10/03/2005
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1225025422
Products in Payments
- AUSTEDO (Drug) $262.59
- AJOVY (Biological) $241.12
- SOLIRIS (Drug) $153.65
- AJOVY (Drug) $132.09
- ULTOMIRIS (Biological) $124.27
- Austedo XR (Drug) $122.46
- COPAXONE (Drug) $110.00
- NUEDEXTA (Drug) $88.50
- Betaseron (Drug) $88.24
- TYSABRI (Biological) $87.62
- ESOPHYX (Device) $85.67
- APTIOM (Drug) $79.26
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $78.50
- Briviact (Drug) $74.07
- Fycompa (Drug) $73.18
- INGREZZA (Drug) $69.43
- Vimpat (Drug) $65.04
- NUPLAZID (Drug) $63.74
- XARELTO (Drug) $57.71
- Soliris (Drug) $51.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.